Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mattia Boeri

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 31, 2022
Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening TrialUgo Pastorino, Vito Ladisa, Sara Trussardo, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
Prognostic determinants in epithelioid sarcomaPatrizia Gasparini, Federica Facchinetti, Mattia Boeri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 22, 2021
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based TreatmentsCristina Borzi, Monica Ganzinelli, Elisa Caiola, et al.
Translational Lung Cancer Research|July 18, 2020
Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score systemArsela Prelaj, Claudia Proto, Giuseppe Lo Russo, et al.
International Journal of Cancer|November 15, 2018
Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer riskOrazio Fortunato, Cristina Borzi, Massimo Milione, et al.
Cancers|September 20, 2019
Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in RhabdomyosarcomaPatrizia Gasparini, Orazio Fortunato, Loris De Cecco, et al.
Clinical Lung Cancer|August 10, 2022
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung CancerGiulia Galli, Paola Antonia Corsetto, Claudia Proto, et al.
Cancers|January 21, 2022
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with ImmunotherapyArsela Prelaj, Mattia Boeri, Alessandro Robuschi, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 14, 2026
Circulating extracellular vesicles from early-stage lung cancer patients trigger endothelial activation to drive pre-metastatic niche formation through synergistic miR-29a and C4A signalingFrancesca Pontis, Patrizia Ghidotti, Nicole Ferrario, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 BlockadeGiuseppe Lo Russo, Massimo Moro, Michele Sommariva, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 31, 2022
Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening TrialUgo Pastorino, Vito Ladisa, Sara Trussardo, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
Prognostic determinants in epithelioid sarcomaPatrizia Gasparini, Federica Facchinetti, Mattia Boeri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 22, 2021
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based TreatmentsCristina Borzi, Monica Ganzinelli, Elisa Caiola, et al.
Translational Lung Cancer Research|July 18, 2020
Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score systemArsela Prelaj, Claudia Proto, Giuseppe Lo Russo, et al.
International Journal of Cancer|November 15, 2018
Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer riskOrazio Fortunato, Cristina Borzi, Massimo Milione, et al.
Cancers|September 20, 2019
Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in RhabdomyosarcomaPatrizia Gasparini, Orazio Fortunato, Loris De Cecco, et al.
Clinical Lung Cancer|August 10, 2022
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung CancerGiulia Galli, Paola Antonia Corsetto, Claudia Proto, et al.
Cancers|January 21, 2022
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with ImmunotherapyArsela Prelaj, Mattia Boeri, Alessandro Robuschi, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 14, 2026
Circulating extracellular vesicles from early-stage lung cancer patients trigger endothelial activation to drive pre-metastatic niche formation through synergistic miR-29a and C4A signalingFrancesca Pontis, Patrizia Ghidotti, Nicole Ferrario, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 BlockadeGiuseppe Lo Russo, Massimo Moro, Michele Sommariva, et al.
Pageof 6